
Post-operative Pain (POP) - Competitive Landscape
Description
Post-operative Pain (POP) - Competitive Landscape
Summary
This reports provides a data-driven overview of the current and future competitive landscape in POP therapeutics.
- In 2024, more than 34,000,000 incident cases of POP are anticipated in the 16 countries covered in GlobalData’s epidemiology forecast for POP.
- Most marketed drugs for POP are enzyme inhibitors, followed by receptor agonists, by mechanism of action.
- Phase III pipeline for POP is robust and includes 27 drugs, while pre-registration comprises four drugs.
- Approximately 39.34% of the clinical trials initiated over the last 10 years for POP have been conducted in sites across Asia-Pacific.
- Acquisitions were the most prevalent deal type in North America, Europe, and Asia-Pacific.
GlobalData’s POP: Competitive Landscape combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.
Components of the report include -
- Disease Landscape
- Disease Overview
- Epidemiology Overview
- Treatment Overview
- Marketed Products Assessment
- Breakdown by Mechanism of Action, Route of Administration
- Product Profiles with Sales Forecast
- Pricing and Reimbursement Assessment
- Annual Therapy Cost
- Time to Pricing and Time to Reimbursement
- Pipeline Assessment
- Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
- Product Profiles with Sales Forecast
- Late-to-mid-stage Pipeline Drugs
- Phase Transition Success Rate and Likelihood of Approval
- Clinical Trials Assessment
- Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
- Enrolment Analytics, Site Analytics, Feasibility Analysis
- Deals Landscape
- Mergers, Acquisitions, and Strategic Alliances by Region
- Overview of Recent Deals
- Commercial Assessment
- Key Market Players
- Future Market Catalysts
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the POP market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global POP market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Table of Contents
91 Pages
- Report Scope
- Abbreviations
- Key Findings
- Disease Etiology
- Epidemiology Overview - Incident Cases of POP in 2024 and 2028
- Treatment Guidelines
- Management Algorithm - Multimodal Pain Control in POP for Hand Surgery
- Marketed Drugs - Leading Marketed Drugs in POP
- Marketed Drugs - Overview by Mechanism of Action
- Marketed Drug Profile - Heron Therapeutics's Zynrelef
- Marketed Drug Profile - Hyloris Pharmaceuticals's Combogesic
- Marketed Drug Profile - Sino Biopharmaceutical's Kaifen
- Marketed Drug Profile - Merck's Hetori
- Marketed Drug Profile - Daiichi Sankyo's Loxonin
- Marketed Drug Profile - Mundipharma's OxyNorm/Endain
- Marketed Drug Profile - Rayner Intraocular Lenses's Omidria
- Marketed Drug Profile - B. Braun Melsungen's Ameniflac
- Marketed Drug Profile - Jiangsu Hengrui Medicine's Bupivacaine
- Marketed Drug Profile - Innocoll Holding's Xaracoll
- Marketed Drug Profile - DURECT Corp's Posimir
- Marketed Drug Profile - Jiangsu Hengrui Medicine's Aisut
- Marketed Drug Profile - Cristalia Produtos Quimicos Farmaceutico's Fentanest Bolsa
- Marketed Drug Profile - Halex Istar Industria Farmaceutica's Axiflennid
- Marketed Drug Profile - Juno Pharmaceutical/Halex Istar Industria Farmaceutica's Naproxen
- Marketed Drug Profile - Johnson & Johnson's Dolormin Duro/Motrimax
- Marketed Drug Profile - Trevena's Olinvyk
- Marketed Drug Profile - Talphera's Zalviso
- Marketed Drugs - Annual Cost of Therapy
- Pipeline Drugs Overview - Late-Stage Pipeline Drugs in POP
- Pipeline Drugs - Overview by Development Stage
- Pipeline Drugs - Overview by Mechanism of Action
- Pipeline Drugs - Overview by Molecule Type
- Pipeline Drugs - Phase Transition Success Rate and Likelihood of Approval in POP
- Pipeline Drugs - Phase Transition Success Rate and Likelihood of Approval in CNS & POP
- Clinical Trials in POP - Historical Overview
- Clinical Trials in POP - Overview by Phase
- Clinical Trials in POP - Overview by Status
- Clinical Trials in POP - Overview by Phase for Ongoing and Planned Trials
- Clinical Trials in POP - Trials with a Virtual Component
- Clinical Trials in POP - Geographic Overview
- Clinical Trials in POP - Single-Country and Multinational Trials by Region
- Clinical Trials in POP - Top 20 Sponsors with Breakdown by Phase
- Clinical Trials in POP - Top 20 Commercial Sponsors with Breakdown by Phase
- Clinical Trials in POP - Top 20 Sponsors with Breakdown by Status
- Clinical Trials in POP - Top 20 Commercial Sponsors with Breakdown by Status
- Clinical Trials in POP - Overview by Endpoint Status
- Clinical Trials in POP - Overview by Race and Ethnicity
- Clinical Trials in POP - Enrollment Data
- Clinical Trials in POP - Overview of Sites by Geography
- Clinical Trials in POP - Top 20 Countries for Trial Sites
- Clinical Trials in POP - Top 20 Sites Globally
- Clinical Trials - Feasibility Analysis: Geography Overview
- Clinical Trials - Feasibility Analysis: Benchmark Models for POP
- Deals Landscape - Mergers, Acquisitions, and Strategic Alliances in POP by Region
- Deals Landscape - Recent Mergers, Acquisitions, and Strategic Alliances in POP
- Commercial Assessment - Key Market Players in POP
- Future Market Catalysts - Upcoming Market Catalysts in POP
- Methodology - Sales Forecasts
- Methodology
- Methodology - Pricing and Reimbursement
- Methodology - Phase Transition Success Rate and Likelihood of Approval Analysis
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.